Why are Medicare and Medicaid shown separately instead of combined?

They come from two different CMS data sources with no shared claim identifier, so they can't be reconciled into one number without double-counting or guessing. Every table and chart on this page keeps them fully separate.

Why is there no private/commercial revenue figure?

Private and commercial payer data comes from Transparency in Coverage files, which only publish negotiated rates — not claims or utilization volume. Without a volume figure, no revenue number can be computed for any provider from that data.

What does "Rank" mean in the Competitive Analysis & Benchmarks tables?

For a given CPT/HCPCS code, it's this provider's position by claims volume among all providers billing that same code at that geography level (State, National, or West Virginia for Medicaid) — rank 1 means the highest claims volume for that code.

Why is the Medicaid comparison limited to West Virginia only?

Medicaid is administered per-state with no single national fee schedule, so a state or national comparison the way Medicare has one isn't available. West Virginia (this provider's own state) is the only grouping that's conceptually meaningful.

Why are the numbers rounded to the nearest 10?

To avoid implying more precision than the underlying data supports at a single-provider level. Ratios are kept precise since they're a relative comparison, not a volume or dollar figure.

How current is this data?

The Medicare and Medicaid tables are both single current snapshots, not refreshed on a recurring schedule yet.

Wassim Saikali (NPI 1992755201)

Field	Value
Entity Type	Individual
Organization	Wassim Saikali
Address	421 Carriage Dr
City	Beckley
State	WV
ZIP	25801
Taxonomy	Rheumatology Physician
NPI Enumerated	May 10, 2006

Payer Source	Total Paid
Medicare	$1.2M
Medicaid	$0

Key Findings

This provider is effectively single-payer from an operational perspective: lifetime Medicare revenue is $1.2M while Medicaid revenue is listed as none (no Medicaid billing on file). That concentration means the practice’s revenue and utilization patterns are driven almost entirely by Medicare patients and Medicare-covered services.

Revenue is highly concentrated in a small set of injectable biologic and specialty drug codes: the precomputed top three Medicare codes account for 79.1% of the provider’s total Medicare revenue, with J0129 ($429.3K revenue, 35.9% of this provider's total Medicare revenue), J0717 ($323.2K revenue, 27.0% of this provider's total Medicare revenue), and J0897 ($194.4K revenue, 16.2% of this provider's total Medicare revenue) together dominating receipts. This concentration signals that buy-and-bill drug administration is the primary revenue driver rather than office visits or procedures.

The code mix and top-revenue items are consistent with an office-based rheumatology practice that administers high-volume injectable biologics and manages bone health: J0129 (abatacept), J0717 (certolizumab pegol) and J0897 (denosumab) are all injectable therapies, and the presence of 77080 (DXA, $8.3K revenue) supports routine osteoporosis assessment. Ancillary codes for joint injections (20610) and intra-articular hyaluronan (J7321) further indicate procedurally active outpatient care focused on musculoskeletal and autoimmune conditions.

Competitive standing for the top drug-admin codes is mixed: J0129 ranks #329 of 1221 providers nationally (73th percentile; typical, unremarkable volume for this code) and J0717 ranks #208 of 848 providers nationally (75th percentile; typical, unremarkable volume for this code), indicating the provider is a modest, not dominant, national participant for those specific biologic administrations. By contrast, J0897 ranks #1006 of 10057 providers nationally (90th percentile; typical, unremarkable volume for this code), showing relatively higher national activity on denosumab compared with peers.

Office visit E/M billing is a notable outlier relative to national peers: 99214 shows 1K claims, $83 avg paid/claim, $86.7K revenue (7.2% of this provider's total Medicare revenue) and ranks #10247 of 479517 providers nationally (98th percentile; notably above typical national volume for this code), while 99213 shows 1K claims, $55 avg paid/claim, $56.7K revenue (4.7% of this provider's total Medicare revenue) and ranks #6004 of 457151 providers nationally (99th percentile; extreme outlier, far above typical national volume for this code). These labels and ranks suggest the practice generates unusually high visit volume relative to peers, consistent with frequent follow-up or chronic disease management workflows.

Beyond the three top J-codes and E/M visits, the provider bills a set of supportive infusion and injection services (96413, 96401, 96365, 96372) and procedural codes (20610, 20600, J7321) at typical national volumes, indicating a mixed model that combines drug administration with hands-on procedural care. Examples include 96413 (283 claims, $24.6K revenue) and 20610 (342 claims, $17.1K revenue), which support an infusion/injection-heavy outpatient practice rather than a purely consulting-only model.

The provider has an established enrollment history (NPI enumerated 2006-05-10, ~20 years ago), which combined with a sustained $1.2M lifetime Medicare revenue profile suggests a stable, long-running Medicare-facing practice rather than a recent entrant. That longevity plus concentrated drug-administration revenue implies entrenched operational processes for buy-and-bill and in-office infusions.

Implications for payers and network managers: absence of Medicaid billing (none on file) means Medicaid plans will not see claims history to evaluate in-state volume or utilization patterns, and contracting or care-management outreach should be Medicare-focused. Given the heavy reliance on a small set of J-codes for the bulk of revenue, payers should prioritize review of buy-and-bill arrangements, drug acquisition costs, and infusion-site-of-care patterns when assessing financial exposure and negotiating terms with this provider.

Medicare: Complete Services Breakdown

The CPT/HCPCS codes generating the most Medicare revenue for this provider.

33 rows

CPT/HCPCS Code	Description	Claims	Avg Paid	Revenue
J0129	Injection, abatacept, 10 mg (code may be used for medicare when drug administered under the direct supervision of a physician, not for use when drug is self administered)	12,630	$30	$429.3K
J0717	Injection, certolizumab pegol, 1 mg (code may be used for medicare when drug administered under the direct supervision of a physician, not for use when drug is self administered)	80,800	$1	$323.2K
J0897	Injection, denosumab, 1 mg	10,800	$20	$194.4K
99214	The provider sees an established patient for an office visit or other outpatient visit involving evaluation and management. The visit involves a moderate level of medical decision making, and/or the…	1,050	$80	$86.7K
99213	The provider sees an established patient for an office visit or other outpatient visit involving evaluation and management. The visit involves a low level of medical decision making, and/or the…	1,030	$60	$56.6K
96413	Chemotherapy is a therapeutic procedure used for the treatment of cancer via the use of chemical agents. These chemical agents (drugs) work on the cancerous cells of the body to destroy them. These…	280	$90	$24.6K
20610	In this procedure, the provider inserts a needle through the skin of a patient and into a major joint or bursa and then uses the syringe attachment to the needle to remove fluid or he may inject a…	340	$50	$17.1K
96401	The provider administers nonhormonal, antineoplastic chemotherapy drugs subcutaneously or intramuscularly to the patient.	240	$50	$10.7K
J7321	Hyaluronan or derivative, hyalgan, supartz or visco-3, for intra-articular injection, per dose	160	$60	$9.2K
99204	The provider sees a new patient for an office visit or other outpatient visit involving evaluation and management. The visit involves a moderate level of medical decision making, and/or the provider…	90	$110	$9K

Showing 1–10 of 33

Medicare: Competitive Analysis & Benchmarks

How this provider's Medicare billing volume and revenue compare to other providers nationally and within its state, across 33 CPT/HCPCS codes.

View: State1 / 2

Claims Volume vs. West Virginia Distribution

Wassim Saikali — 8 of 25 codes billed far more than typical (above p95)

p5–p95 (all providers)p25–p75MedianThis providerOutlier

Rank Distribution — West Virginia

Full comparison — all codes billed, vs. state median

33 rows

CPT/HCPCS Code	Rank	Provider Count	Median Claims	Avg Paid	Average Revenue
J0717	1	10	80,800	$1	$315.7K
J0129	1	10	9,000	$30	$299.3K
J0897	1	20	2,160	$20	$50.3K
96413	3	10	170	$90	$19.5K
99214	12	2,740	100	$70	$11.8K
J7321	2	10	130	$60	$7.9K
99213	29	2,860	80	$50	$7.5K
96365	6	10	110	$50	$5.5K
20610	21	240	60	$40	$5.3K
96401	1	10	100	$50	$5K

Showing 1–10 of 33

Related Providers

Other providers that share a Tax Identification Number (TIN) with Wassim Saikali, ranked by combined Medicare and Medicaid revenue.

Provider	State	Taxonomy	Medicare Revenue	Medicaid Revenue
Maria Boustani	WV	Pulmonary Disease Physician	$202.6K	$0

Nearby Providers

Other providers in the same ZIP code as Wassim Saikali, ranked by combined Medicare and Medicaid revenue.

Provider	State	Taxonomy	Medicare Revenue	Medicaid Revenue
Raleigh General Hospital LLC	WV	General Acute Care Hospital	$0	$36.4M
Community Health Systems, Inc.	WV	Federally Qualified Health Center (FQHC)	$0	$35M
Fmrs Health Systems Inc	WV	Community/Behavioral Health Agency	$0	$27M
Health Care Alliance, Inc.	WV	Emergency Medicine Physician	$0	$25M
Jan-care Ambulance Of Raleigh County Inc	WV	Land Ambulance	$1.9M	$20.8M
Appalachian Regional Healthcare, Inc	WV	General Acute Care Hospital	$0	$18.3M
Raleigh County Commission On Aging, Inc.	WV	Home Health Agency	$0	$16.7M
Mountain State Home Health Care Inc	WV	Nursing Care Agency	$0	$16.5M
Family Options Providers, LLC.	WV	Community/Behavioral Health Agency	$0	$16.1M
Raleigh County Commission On Aging, Inc.	WV	Home Health Agency	$0	$13.8M

Wassim Saikali — Billing Profile & Reimbursement Data

Sign up for Wassim Saikali — Billing Profile & Reimbursement Data policy alerts

Wassim Saikali — Billing Profile & Reimbursement Data

Sign up for Wassim Saikali — Billing Profile & Reimbursement Data policy alerts

Key Findings

Medicare: Total Revenue Breakdown by CPT/HCPCS Code

Medicare: Complete Services Breakdown

Medicare: Competitive Analysis & Benchmarks

Related Providers

Nearby Providers

Frequently Asked Questions

References